Dr. Ponni V. Perumalswami is an Assistant Professor of Medicine in the Division of Liver Diseases at the Mount Sinai School of Medicine. She earned her B.S. from the University of Michigan, graduating with honors. She completed her Internal Medicine residency at George Washington University. She went on to complete fellowship training in Gastroenterology at New York University and a Transplant Hepatology fellowship at the Mount Sinai Medical Center.
Dr. Perumalswami's areas of clinical interest include cirrhosis, acute/chronic liver diseases and liver transplantation. Her research program focuses on community outreach for hepatitis B and C screening and linking patients to care. She is an investigator for many ongoing clinical trials evaluating the safety and efficacy of new antiviral treatments for chronic hepatitis B and C.
Dr. Perumalswami is an UNOS-certified Liver Transplant physician and is board certified in Internal Medicine, and Gastroenterology. She is also board eligible in Transplant Hepatology. Currently she is a member of the American Association for the Study of Liver Diseases, European Association for the Study of the Liver and the American Gastroenterology Association.
Dr. Perumalswami is fluent in English and Tamil.
MD, Wayne State University
Residency, Internal Medicine
George Washington University
NYU Medical Center
English, Tamil (India)
AASLD Advanced Hepatology Award
Liver Transplant Fellowship
Perumalswami PV, Kleiner DE, Lutchman G, Heller T, Bozorg B, Park Y, Liang TJ, Hoofnagle JH, Ghany MG. Steatosis and Progression of Fibrosis in Untreated Patients with Chronic Hepatitis C Infection. Hepatology 2006; 43: 780-787.
Perumalswami PV, J BE. Epidemiology, natural history, and treatment of hepatitis B virus and hepatitis C virus coninfection. Minerva Gastroenterol Dietol 2006; 52: 145-55.
Perumalswami PV, Bini EJ. Vaccination against Hepatitis A and B in Patient with Chronic Liver Disease, Hepatitis Vaccinations; The Year in Review supplement to Current Hepatitis Reports. 2007 January;.
A Long-Term Follow-up Study to Evaluate the Durability of Virologic Response and/or Viral Resistance Patterns of Subjects with Chronic Hepatitis C Who Have Been Previously Treated with MK-5172 in a Prior Clinical Trial
A Randomized Open-Label Multicenter Study to Evaluate the Efficacy Safety and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 or Genotype 3
A Phase III Double Blind Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Treatment-Naïve Subjects with Chronic HCV GT1, GT4 and GT6 Infection with Inherited Blood Disorders with and without HIV Co-Infection
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Perumalswami did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.